PUBLIC COMPANY
saveViiV Healthcare Company
updated 21d ago
community read0 votes
🐶 often sniffed alongside
top 4pipeline
13
marketed
13
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(13)
view full pipeline →pipeline depth13 products
13Marketed
Marketed
(abacavir sulfate + dolutegravir sodium + lamivudine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed(abacavir sulfate + dolutegravir sodium+ lamivudine) ODT
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed(dolutegravir sodium + lamivudine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed(dolutegravir sodium + rilpivirine hydrochloride)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedabacavir sulfate
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedcabotegravir + rilpivirine LA
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedcabotegravir LA
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedcabotegravir sodium
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketeddolutegravir sodium
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketeddolutegravir sodium ODT
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedfostemsavir tromethamine ER
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketedlamivudine
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaquesCytoDyn's leronlimab may have struggled to secure approval as an HIV treatment, but research in infant primates has offered fresh hope for the CCR5-targeting antibody's ability to treat the virus.fiercebiotech · 9d ago
- STAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicineA South American court upheld the steps taken by the Colombian government when it issued a compulsory license two years ago for an HIV medicine.stat · 3mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that